(Q45997955)

English

Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).

scientific article published on 23 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/25158109

Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/25158109

0 references

allergic bronchopulmonary aspergillosis

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Livingstone Chishimba

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Philip Langridge

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Georgina Powell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

David W Denning

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

0 references

publication date

23 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/25158109

Journal of Asthma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

289-295

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

An ongoing Confidential Enquiry into asthma deaths in the Eastern Region of the UK, 2001-2003.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Death rates for asthma in English populations 1979-2007: comparison of underlying cause and all certified causes

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Clinical, economic, and humanistic burden of asthma in Canada: a systematic review

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-88.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Inhaled corticosteroids in COPD and the risk of serious pneumonia

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Antifungals in the treatment of allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

The link between fungi and severe asthma: a summary of the evidence.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Summary of the 2008 BTS/SIGN British Guideline on the management of asthma.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA: Figure 1–

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2014.958853

21 January 2018

Identifiers

10.3109/02770903.2014.958853

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45997955&oldid=1560120949"